Clinical Trial Detail

NCT ID NCT00702884
Title Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ohio State University Comprehensive Cancer Center
Indications

esophageal carcinoma

gastroesophageal junction adenocarcinoma

Therapies

Sunitinib

Age Groups: adult

No variant requirements are available.